Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients

[1]  D. Grignon,et al.  EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma , 2021, Modern Pathology.

[2]  J. Cheville,et al.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia , 2021, Modern Pathology.

[3]  J. Cheville,et al.  Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia , 2021, Modern Pathology.

[4]  B. Delahunt,et al.  Granular necrosis: a distinctive form of cell death in malignant tumours. , 2020, Pathology.

[5]  C. Pan,et al.  ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217 , 2020, Modern Pathology.

[6]  D. Grignon,et al.  Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer. , 2020, The American journal of surgical pathology.

[7]  S. Dhanasekaran,et al.  Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series , 2019, Medical Oncology.

[8]  A. Sangoi,et al.  Low‐grade oncocytic tumour of kidney (CD117‐negative, cytokeratin 7‐positive): a distinct entity? , 2019, Histopathology.

[9]  R. Tothill,et al.  Bayesian approach to determining penetrance of pathogenic SDH variants , 2018, Journal of Medical Genetics.

[10]  S. Fox,et al.  SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response , 2018, npj Precision Oncology.

[11]  P. Argani,et al.  Re‐evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patients , 2018, Histopathology.

[12]  A. Gill.  Succinate dehydrogenase (SDH)‐deficient neoplasia , 2018, Histopathology.

[13]  Soo-Mi Park,et al.  Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review , 2017, The Journal of clinical endocrinology and metabolism.

[14]  Yingbei Chen,et al.  A distinctive, low‐grade oncocytic fumarate hydratase‐deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase‐deficient renal cell carcinoma , 2017, Histopathology.

[15]  G. Netto,et al.  Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma. , 2015, Human pathology.

[16]  Yingyong Hou,et al.  A novel germline mutation in SDHA identified in a rare case of gastrointestinal stromal tumor complicated with renal cell carcinoma. , 2015, International journal of clinical and experimental pathology.

[17]  J. Ross,et al.  A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling , 2015, The American journal of surgical pathology.

[18]  M. Amin,et al.  Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma , 2015, Modern Pathology.

[19]  T. Dwight,et al.  Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas , 2014, The American journal of surgical pathology.

[20]  L. Lipton,et al.  Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma. , 2013, Pathology.

[21]  T. Dwight,et al.  Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma. , 2013, The Journal of clinical endocrinology and metabolism.

[22]  L. Lipton,et al.  Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors , 2013, The American journal of surgical pathology.

[23]  W. Linehan,et al.  Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. , 2012, The Journal of urology.

[24]  A. Gill.  Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia , 2012, Pathology.

[25]  A. Chou,et al.  Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology , 2011, The American journal of surgical pathology.

[26]  W. Dinjens,et al.  SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. , 2011, The Journal of clinical endocrinology and metabolism.

[27]  A. Gill,et al.  Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4. , 2011, The New England journal of medicine.

[28]  A. Chou,et al.  Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. , 2010, Human pathology.

[29]  A. Chou,et al.  Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types , 2010, The American journal of surgical pathology.